EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Filipov, N. M.
Right arrow Articles by Smith, C. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Filipov, N. M.
Right arrow Articles by Smith, C. K.
Proceedings of the Society for Experimental Biology and Medicine 225:136-142 (2000)
© 2000 Society for Experimental Biology and Medicine


Original Article

Anti-Inflammatory Effects of Ergotamine in Steers

Nikolay M. Filipov*,2, Frederick N. Thompson*,1, John A. Stuedemann{dagger}, Theodore H. Elsasser{ddagger}, Stanislaw Kahl{ddagger}, Larry H. Stanker§, Colin R. Young§, Donald L. Dawe and Charles K. Smith*


* Departments of Physiology and Pharmacology and
Medical Microbiology, College of Veterinary Medicine, University of Georgia, Athens, Georgia 30602;
{dagger} J. Phil Campbell, Sr., Natural Resource Conservation Center, United States Department of Agriculture, Agricultural Research Service, Watkinsville, Georgia 30677;
{ddagger} Growth Biology Laboratory, United States Department of Agriculture, Agricultural Research Service, Beltsville, Maryland 20705; and
§ Food Animal Protection Research Laboratory, United States Department of Agriculture, Agricultural Research Service, College Station, Texas 77845

The objective of this experiment was to investigate whether the ergot alkaloid, ergotamine (ET), an alkaloid used to model fescue toxicosis in cattle, modifies the response of cattle to endotoxin (LPS) challenge. Steers (n = 16) were divided into the following treatment groups: control (C), ergotamine (ET), endotoxin (LPS), and ET + LPS. ET and ET + LPS groups received a single bolus intravenous injection of ET (40 µg · kg · body wt-1), whereas C and LPS steers received a single bolus injection of sterile vehicle. Thirty minutes after ET/vehicle administration, a single bolus intravenous injection of LPS (0.2 µg · kg · body wt-1) was given. Blood was collected at various time points for 48 hr post. Endotoxin increased rectal temperature (RT) and the circulating levels of tumor necrosis factor-{alpha} (TNF-{alpha}), cortisol, haptoglobin (Hp), thromboxane B2 (TXB2). The circulating Hp, TNF-{alpha}, and TXB2 increases were blunted by pretreatment with ET compared with ET + LPS. Ergotamine by itself increased circulating cortisol and RT, whereas it decreased serum prolactin (PRL). Therefore, whereas administration of LPS at 0.2 µg/kg to steers resulted in an expected response, the combination of ET + LPS attenuated major effects of LPS alone. Thus, acute administration of ET appeared to be anti-inflammatory as it decreased the inflammatory response to LPS, an effect likely driven at least in part by the ET-caused cortisol increase.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
K. R. Schmelzer, L. Kubala, J. W. Newman, I.-H. Kim, J. P. Eiserich, and B. D. Hammock
Soluble epoxide hydrolase is a therapeutic target for acute inflammation
PNAS, July 12, 2005; 102(28): 9772 - 9777.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Society for Experimental Biology and Medicine.